The use of a new vasoconstrictor in the management of burns.
D000768:Anesthesia, General; D002056:Burns / Q000601:surgery*; D002648:Child; D004837:Epinephrine / Q000009:adverse effects; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D007223:Infant; D009638:Norepinephrine / Q000009:adverse effects; D009952:Ornithine / Q000627:therapeutic use; D016038:Skin Transplantation; D014182:Transplantation, Autologous; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014667:Vasopressins / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D014667:Vasopressins; D009952:Ornithine; D009638:Norepinephrine; D004837:Epinephrine